unyango lwe-metastatic renal cell carcinoma

Unyango lweMetastatic Renal Cell Carcinoma: IsiKhokelo esiBanziUkuqonda kunye noLawulo lweMetastatic Renal Cell Carcinoma Eli nqaku libonelela ngamagqabantshintshi abanzi unyango lwe-metastatic renal cell carcinoma (mRCC), ukugubungela ukuxilongwa, ukhetho lonyango, kunye nokunakekelwa kwenkxaso. Ijolise ekuxhobiseni izigulane kunye neentsapho zabo ngolwazi olufunekayo ukuhamba ngolu hambo olunzima. Siza kuphonononga iindlela ezahlukeneyo zonyango, kubandakanywa unyango ekujoliswe kulo, unyango lwe-immunotherapy, kunye notyando, sigxininisa ukubaluleka kwezicwangciso zokhathalelo lomntu ngokusekelwe kwizinto zesigulana ngasinye. Ngaphaya koko, siza kujongana neziphumo ebezingalindelekanga kunye nezicwangciso zokuzilawula. Khumbula, olu lwazi lwenzelwe iinjongo zemfundo kwaye akufuneki luthathe indawo yengcebiso yezonyango. Soloko udibana nomboneleli wakho wezempilo ukuze ufumane ukuxilongwa kunye nonyango.

Ukuxilongwa kweMetastatic Renal Cell Carcinoma

Ukuchonga i-mRCC

Ukuxilongwa kwe I-metastatic renal cell carcinoma iqala ngembali yonyango ecokisekileyo, ukuhlolwa komzimba, kunye novavanyo lwemifanekiso efana ne-CT scans, i-MRI scans, kunye ne-PET scans. Olu vavanyo lunceda ukuchonga ubukho kunye nobungakanani bomhlaza, kubandakanywa nokuba usasazeke na (i-metastasized) kwamanye amalungu omzimba. I-biopsy, ukususwa kwesampulu encinci yethishu kuvavanyo lwe-microscopic, ihlala iyimfuneko ukuze kuqinisekiswe ukuxilongwa kunye nokumisela uhlobo oluthile lomhlaza wezintso. Ukufunyaniswa kwangethuba kubalulekile, njengenqanaba lokuqala mRCC idla ngokunyangeka.

Ukubonisa i-mRCC

Iqonga limisela ubungakanani bokunwenwa komhlaza. Oku kwenziwa ngokusebenzisa inkqubo efana ne-TNM staging system, eqwalasela ubungakanani kunye nendawo ye-tumor ephambili (T), ukubandakanyeka kwee-lymph nodes zengingqi (N), kunye nobukho be-metastasis ekude (M). Inqanaba lichaphazela iingcebiso zonyango kunye ne-prognosis.

Iinketho zonyango lweMetastatic Renal Cell Carcinoma

Unyango ekujoliswe kulo

Unyango olujoliswe kuyo ngamayeza enzelwe ukuphazamisa iimolekyuli ezithile ezibandakanyekayo ekukhuleni kweeseli zomhlaza kunye nokuphila. Iindlela ezininzi zonyango ekujoliswe kuzo zibonakalise ukusebenza ngempumelelo ekunyangeni mRCC, kuquka i-tyrosine kinase inhibitors (TKIs) njenge sunitinib, pazopanib, kunye ne axitinib. La machiza anokunciphisa amathumba kwaye aphucule ubomi. Ukhetho lonyango olujoliswe kuyo luxhomekeke kwizinto ezifana nempilo yonke yesigulane, uhlobo oluthile lwe mRCC, kunye nobukho bazo naziphi na ezinye iimeko zonyango.

Immunotherapy

I-Immunotherapy idibanisa amajoni omzimba ukulwa nomhlaza. I-Checkpoint inhibitors, njenge-nivolumab kunye ne-ipilimumab, isetyenziswa ngokuqhelekileyo kuyo mRCC unyango. La machiza avimba iiproteni ezithintela amajoni omzimba ekuhlaseleni iiseli zomhlaza, evumela amajoni omzimba ukuba ajolise ngokufanelekileyo kwaye aphelise iiseli zethumba. I-Immunotherapy inokusebenza kakhulu, kodwa iziphumo ebezingalindelekanga zinokwenzeka.

Unyango lweCytokine

I-Interleukin-2 (IL-2) yonyango ye-cytokine esetyenziswa kwezinye iimeko ze mRCC. Ivuselela amajoni omzimba ukuba ahlasele iiseli zomhlaza. Ngelixa isebenzayo kwezinye izigulana, unyango lwe-IL-2 lunxulunyaniswa neziphumo ebezingalindelekanga kwaye alufanelekanga kumntu wonke.

Utyando

Utyando lunokuba lukhetho kwiimeko ezithile, ezinjengokususa ithumba lendawo okanye ukunciphisa iimpawu ezibangelwa ngumhlaza. Nangona kunjalo, utyando alufane lunyange kwinkqubela phambili mRCC.

Ukhathalelo lweNkxaso kwizigulana ezine-mRCC

Ukulawula iziphumo ebezingalindelekanga ezinxulumene ne mRCC unyango lubalulekile ekuphuculeni umgangatho wobomi bezigulane. Ukunyamekelwa kwenkxaso kubandakanya ukulawulwa kweentlungu, inkxaso yesondlo, kunye neengcebiso zengqondo. I IZiko loPhando ngoMhlaza laseShandong Baofa inikezela ngeenkonzo zokhathalelo olubanzi lwenkxaso ukunceda izigulane ukumelana nemingeni ye mRCC.

Iimvavanyo zeklinikhi

Ukuthatha inxaxheba kwiimvavanyo zeklinikhi yindlela yokukhetha izigulane ezine mRCC. Ulingo lwezonyango luvavanya unyango olutsha kunye neendlela, ezinokuthi zinike ufikelelo kunyango olutsha olusenokungafumaneki ngokubanzi.

I-Prognosis kunye noLawulo lwexesha elide

I-prognosis yezigulane ezine I-metastatic renal cell carcinoma iyahluka ngokuxhomekeke kwizinto eziliqela, kuquka inqanaba lomhlaza, impilo yesigulana ngokubanzi, kunye nempendulo kunyango. Ukuqeshwa okulandelwa rhoqo kubalulekile ekubekeni iliso ukuqhubeka kwesifo kunye nokulawula naziphi na iingxaki ezinokubakho. Ukuguqulwa kwendlela yokuphila, njengokugcina ukutya okunempilo kunye nokuzivocavoca rhoqo, kunokudlala indima exhasayo ekuphuculeni umgangatho wobomi.

Ukuthelekiswa koKhetho loNyango

Uhlobo loNyango	Indlela yokwenza	Iziphumo ezisecaleni	Ukufaneleka
Unyango ekujoliswe kulo	Iphazamisana neemolekyuli ezithile ezibandakanyekayo ekukhuleni kweeseli zomhlaza.	Ukudinwa, isicaphucaphu, uxinzelelo lwegazi oluphezulu.	Ifanelekile kwizigulana ezininzi ezine-mRCC.
Immunotherapy	Ivuselela amajoni omzimba ukuba ahlasele iiseli zomhlaza.	Ukudinwa, ukubetha kwesikhumba, urhudo.	Ifanelekile kwezinye izigulana ezine-mRCC, ngakumbi ezo zinee-biomarkers ezithile.
Unyango lweCytokine	Ivuselela amajoni omzimba.	Iziphumo zecala ezibalulekileyo ezibandakanya i-capillary leak syndrome.	Isetyenziswa ngokukhethayo ngenxa yeziphumo ebezingalindelekanga ezibalulekileyo.

I-Disclaimer: Le ngcaciso yenzelwe iinjongo zemfundo kuphela kwaye akufanele ithathwe njengengcebiso yezonyango. Hlala udibana nogqirha wakho okanye omnye umboneleli wezempilo ofanelekileyo ukuba unemibuzo malunga nempilo yakho okanye ufuna iingcebiso zonyango. Ulwazi olunikelwe apha lusekelwe kulwazi lwangoku lwezonyango kwaye lusenokutshintshwa.Iimbekiselo: (Eli candelo liza kubandakanya ukucatshulwa okuvela kwimithombo ethembekileyo efana neNational Cancer Institute, i-American Society of Clinical Oncology, kunye neejenali zonyango ezifanelekileyo. Ezi ziya kufomathwa ngokwendlela yokucaphula engatshintshiyo.)